| Literature DB >> 30268131 |
Sung Yoon Lim1, Won Gun Kwack1, Youlim Kim1, Yeon Joo Lee1, Jong Sun Park1, Ho Il Yoon1, Jae Ho Lee1, Choon-Taek Lee1, Young-Jae Cho2.
Abstract
BACKGROUND: Percutaneous tracheostomy (PT) is a common procedure in critical care medicine. No definite clinical practice guidelines recommended on the choice of the direction of skin incision, vertical or transverse for tracheostomy in critically ill patients. The objective of this retrospective study was to compare the outcomes associated with vertical and transverse skin incisions in patients undergoing PT.Entities:
Keywords: Percutaneous tracheostomy; Tracheostomy site ulcers; Transverse skin incision; Vertical skin incision
Mesh:
Year: 2018 PMID: 30268131 PMCID: PMC6164179 DOI: 10.1186/s13054-018-2174-y
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Fig. 1Diagram showing the flow of participants through each stage of the study
Fig. 2a Stomal site ulcer after vertical incision. b Healed ulcer
Baseline characteristics of the patients who underwent PT
| Characteristics | Vertical | Transverse | |
|---|---|---|---|
| Age, years | 68.4 ± 15.1 | 68.2 ± 15.7 | 0.948 |
| Sex, male (%) | 77 (60.7) | 223 (66.8) | 0.553 |
| BMI | 20.5 ± 4.9 | 20.7 ± 3.7 | 0.294 |
| Duration of mechanical ventilation before PT (day) | 10.6 ± 6.3 | 9.7 ± 7.7 | 0.437 |
| APACHE II | 25.98 ± 6.5 | 26.23 ± 8.3 | 0.567 |
| Reason for tracheostomy (%) | 0.211 | ||
| Need for long-term free airway maintenance | 73 (58.8) | 178 (53.2) | |
| Prolonged mechanical ventilation | 50 (40.3) | 140 (42.0) | |
| Laboratory findings (coagulation) | |||
| Platelets (103/μl) | 207 | 208 | 0.695 |
| PT (INR) | 1.12 | 1.15 | 0.229 |
| aPTT (s) | 40.15 | 39.60 | 0.988 |
| Antiplatelet agent during perioperative period (%) | 17 (13.6) | 36 (10.8) | 0.472 |
| Aspirin | 14 (11.2) | 22 (6.6) | |
| Clopidogrel | 2 (1.6) | 5 (1.5) | |
| Aspirin and clopidogrel | 1 (0.8) | 9 (2.7) | |
| Anticoagulant during perioperative period (%) | 18 (14.7) | 29 (8.7) | 0.039 |
| Operated on by attending physician (%) | 82 (65.3) | 198 (59.3) | 0.190 |
| Periprocedural parameters | |||
| Size of incision (cm) | 1.4 ± 0.2 | 1.3 ± 0.2 | 0.046 |
| Procedure time (min) | 19.3 ± 9.0 | 16.10 ± 8.8 | < 0.005 |
| Length of stay in ICU | 25.4 | 24.0 | 0.001 |
| Length of stay in hospital | 61.6 | 74.8 | 0.067 |
| In-hospital mortality | 30 (24) | 70 (20.8) | 0.494 |
Values are presented as number (%) or mean ± SD
APACHE Acute Physiology and Chronic Health Evaluation, BMI body mass index, PT percutaneous tracheostomy, PT INR the international normalized ratio of prothrombin time, aPTT activated partial thromboplastin time
Postoperative complications in the two groups
| Characteristics | Vertical | Transverse | |
|---|---|---|---|
| Immediate postoperative complications | 24 (19.3) | 41 (12.3) | 0.083 |
| Unintended extubation | 2 (1.6) | 3 (0.9) | 0.513 |
| Bleeding | 0.036 | ||
| Minor (3–5 small, soaked swabs) | 12 (9.7) | 15 (4.5) | |
| Major | 0 (0) | 0 (0) | |
| Tracheal ring fracture visible by bronchoscopy | 7 (5.6) | 18 (5.4) | 0.915 |
| Desaturation (≤ 88% during procedure) | 1 (0.8) | 0 (0) | 0.100 |
| Subcutaneous emphysema | 1 (0.8) | 2 (0.6) | 0.807 |
| Othersa | 1 (0.8) | 3 (0.9) | 0.925 |
| Complications developed within 7 days after PT | 17 (14.1) | 18 (5.4) | 0.001 |
| Delayed bleeding | 2 (1.8) | 1 (0.3) | 0.122 |
| Hematoma | 0 (0) | 1 (0.3) | 0.542 |
| Tracheostomy site ulcer | 8 (6.5) | 4 (1.2) | 0.002 |
| Cellulitis | 3 (2.4) | 4 (1.2) | 0.344 |
| Others (erythema) | 4 (3.2) | 8 (2.4) | 0.621 |
| Long-term complications | 2 (1.6) | 4 (1.2) | 0.728 |
| Tracheal stenosis | 2 (1.6) | 2 (0.6) | 0.358 |
| Tracheomalacia | 0 (0) | 2 (0.6) | 0.388 |
Values are presented as number (%)
PT percutaneous tracheostomy
aTwo patients had hypotension and two had tachycardia
Risk factors for tracheostomy site ulcer identified by multiple logistic regression analyses
| Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
| Odds ratio (95% CI) | Odds ratio (95% CI) | |||
| Age (years) | 1.004 (0.979–1.029) | 0.760 | ||
| Male sex | 1.288 (0.599–2.771) | 0.517 | ||
| Antiplatelet agent during perioperative period | 1.624 (0.668–3.949) | 0.285 | ||
| Anticoagulant agent during perioperative period | 1.239 (0.467–3.289) | 0.667 | ||
| APACHE II | 0.968 (0.920–1.018) | 0.200 | ||
| Duration of MV before PT | 0.977 (0.922–1.034) | 0.415 | ||
| Size of incision | 0.560 (0.171–1.832) | 0.337 | ||
| Procedure time | 0.999 (0.999–1.000) | 0.092 | 0.999 (0.999–1.000) | 0.038 |
| Operated on by attending physician | 0.734 (0.431–1.250) | 0.255 | ||
| Vertical (versus transverse) | 3.014 (1.387–6.554) | 0.005 | 2.821 (1.327–5.996) | 0.007 |
| Immediate postoperative complications | 1.133 (0.481–2.668) | 0.775 |
APACHE Acute Physiology and Chronic Health Evaluation, PT percutaneous tracheostomy, MV mechanical ventilator, CI confidence interval